PPTsInvestor Presentation
Torrent Pharma reported Q3 FY26 total revenue of Rs 3303 Cr, marking an 18% year-on-year growth.
Torrent Pharmaceuticals LimitedTORNTPHARM · Filed with the exchange
For the nine months ending Dec 25, total revenue reached Rs 9783 Cr, a 14% increase from the previous year.
Geographically, Brazil was a standout performer in Q3, growing 27% YoY to Rs 371 Cr.
The United States also showed robust growth, up 19% to Rs 321 Cr in Q3, and 21% YTD.
India's business maintained solid momentum, expanding 14% YoY in Q3 to Rs 1798 Cr and 12% YTD.
The 'Others' segment recorded strong percentage growth, up 32% in Q3. Germany's revenue grew 8% for the quarter and 7% YTD.
No details on profit trends, growth strategies, or management outlook were available.
No comments yet. Be the first.